ĐÁNH GIÁ HIỆU QUẢ CỦA QUANG ĐÔNG THỂ MI XUYÊN CỦNG MẠC BẰNG LASER VI XUNG ĐIỀU TRỊ GLÔCÔM

Abstract

Purpose: Evaluating the efficacy of micropulse transscleral cyclophotocoagulation in treating glaucoma. Patients and method: Uncontrolled clinical trial was practiced in glaucoma patients who met one of the following criteria: Patients with uncontrolled IOP despite maximum lowering IOP agents, patients who have been treated with surgical methods but have failed or carry a high risk of surgical failure. Treatment results are evaluated at 1 week, 1 month, and 3 months after the first laser session. Patients who do not achieve the desired intraocular pressure may consider a second additional laser at least 1 month after the first session. Results: 26 eyes of 25 patients with mean age of 50.2 ± 25.7 years were included in the study. The diagnosis of neovascular glaucoma accounted for the highest rate in the study group (38.5%). The mean IOP before treatment was 37.7 ± 10.5 mmHg decreased to 20.6 ± 8.2 mmHg after 3 months (reduced by 45.4%), the average number of glaucoma eyedrops before treatment was 2.78 reduced to 1.33. On average, each patient received 1.23 laser sessions. The success rate at 3 months after the first laser session was 61.5%. No serious complication was recorded after treatment. Conclusion: Micropulsed laser transscleral photocoagulation is a non-invasive, safe and effective treatment for glaucoma.